Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 44 | 2023 | 7988 | 3.200 |
Why?
|
Amyloid beta-Peptides | 32 | 2023 | 3574 | 1.660 |
Why?
|
Amyloid | 6 | 2023 | 795 | 1.420 |
Why?
|
tau Proteins | 20 | 2023 | 1860 | 1.180 |
Why?
|
Neuropsychological Tests | 22 | 2022 | 6974 | 1.140 |
Why?
|
Mental Recall | 5 | 2019 | 1205 | 0.980 |
Why?
|
Disease Progression | 15 | 2023 | 13256 | 0.890 |
Why?
|
Positron-Emission Tomography | 32 | 2023 | 6259 | 0.840 |
Why?
|
Learning Curve | 1 | 2023 | 200 | 0.840 |
Why?
|
Thiazines | 1 | 2022 | 38 | 0.830 |
Why?
|
Memory | 7 | 2023 | 2163 | 0.820 |
Why?
|
Executive Function | 7 | 2018 | 1362 | 0.820 |
Why?
|
Aging | 11 | 2020 | 8626 | 0.690 |
Why?
|
Aphasia, Primary Progressive | 1 | 2020 | 73 | 0.670 |
Why?
|
Memory Disorders | 6 | 2023 | 1183 | 0.670 |
Why?
|
Cognition Disorders | 5 | 2014 | 4030 | 0.610 |
Why?
|
Brain | 19 | 2023 | 26343 | 0.570 |
Why?
|
Huntington Disease | 2 | 2012 | 1111 | 0.520 |
Why?
|
Cognition | 13 | 2023 | 6722 | 0.510 |
Why?
|
Cues | 2 | 2017 | 868 | 0.500 |
Why?
|
Aniline Compounds | 10 | 2019 | 983 | 0.500 |
Why?
|
Semantics | 2 | 2019 | 584 | 0.450 |
Why?
|
Remedial Teaching | 1 | 2012 | 13 | 0.440 |
Why?
|
Association Learning | 1 | 2014 | 224 | 0.430 |
Why?
|
Thiazoles | 10 | 2019 | 1484 | 0.420 |
Why?
|
Aged | 53 | 2023 | 162944 | 0.410 |
Why?
|
Clinical Trials as Topic | 5 | 2021 | 7901 | 0.400 |
Why?
|
Names | 3 | 2020 | 50 | 0.340 |
Why?
|
Amnesia | 1 | 2011 | 244 | 0.340 |
Why?
|
Face | 2 | 2017 | 993 | 0.340 |
Why?
|
Hippocampus | 6 | 2020 | 3661 | 0.340 |
Why?
|
Memory, Short-Term | 2 | 2012 | 972 | 0.340 |
Why?
|
Psychomotor Performance | 4 | 2018 | 1895 | 0.320 |
Why?
|
Educational Measurement | 1 | 2014 | 1206 | 0.290 |
Why?
|
Aged, 80 and over | 28 | 2023 | 57683 | 0.280 |
Why?
|
Mental Status Schedule | 2 | 2017 | 321 | 0.260 |
Why?
|
Longitudinal Studies | 14 | 2022 | 13921 | 0.250 |
Why?
|
Tauopathies | 2 | 2019 | 307 | 0.250 |
Why?
|
Amyloidogenic Proteins | 3 | 2023 | 151 | 0.230 |
Why?
|
Humans | 67 | 2023 | 742088 | 0.230 |
Why?
|
Psychotherapy | 1 | 2012 | 1644 | 0.220 |
Why?
|
Female | 46 | 2023 | 379592 | 0.220 |
Why?
|
Entorhinal Cortex | 3 | 2023 | 264 | 0.220 |
Why?
|
Male | 44 | 2023 | 349538 | 0.220 |
Why?
|
Feasibility Studies | 2 | 2023 | 5062 | 0.210 |
Why?
|
Apolipoprotein E4 | 4 | 2019 | 667 | 0.210 |
Why?
|
Attention | 1 | 2012 | 2396 | 0.200 |
Why?
|
Atrophy | 3 | 2023 | 1576 | 0.200 |
Why?
|
Australia | 2 | 2022 | 1167 | 0.180 |
Why?
|
Parahippocampal Gyrus | 1 | 2020 | 116 | 0.180 |
Why?
|
Depressive Disorder | 1 | 2012 | 3748 | 0.180 |
Why?
|
Corpus Striatum | 2 | 2018 | 1220 | 0.170 |
Why?
|
Midwifery | 1 | 2020 | 131 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 14 | 2022 | 35342 | 0.160 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 24913 | 0.160 |
Why?
|
Computers | 1 | 2021 | 611 | 0.160 |
Why?
|
Presenilin-1 | 2 | 2020 | 635 | 0.160 |
Why?
|
Apathy | 1 | 2019 | 96 | 0.160 |
Why?
|
Psychometrics | 2 | 2019 | 2999 | 0.150 |
Why?
|
Depression | 2 | 2017 | 7733 | 0.150 |
Why?
|
Locus Coeruleus | 3 | 2023 | 176 | 0.150 |
Why?
|
Reaction Time | 1 | 2023 | 2092 | 0.150 |
Why?
|
Plaque, Amyloid | 1 | 2020 | 729 | 0.140 |
Why?
|
Advisory Committees | 1 | 2021 | 773 | 0.140 |
Why?
|
Activities of Daily Living | 3 | 2023 | 2414 | 0.140 |
Why?
|
Empathy | 1 | 2020 | 472 | 0.130 |
Why?
|
Robotics | 1 | 2023 | 892 | 0.130 |
Why?
|
Temporal Lobe | 3 | 2019 | 1669 | 0.130 |
Why?
|
Middle Aged | 24 | 2023 | 213127 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2021 | 1520 | 0.120 |
Why?
|
Mental Disorders | 1 | 2012 | 6587 | 0.110 |
Why?
|
Cerebral Cortex | 2 | 2020 | 5705 | 0.100 |
Why?
|
Qualitative Research | 1 | 2021 | 2680 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19862 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 719 | 0.100 |
Why?
|
Cerebrovascular Disorders | 1 | 2018 | 1499 | 0.100 |
Why?
|
Amyloidosis | 1 | 2018 | 795 | 0.100 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2012 | 242 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 9941 | 0.100 |
Why?
|
Boston | 1 | 2023 | 9305 | 0.090 |
Why?
|
Nerve Degeneration | 1 | 2015 | 748 | 0.090 |
Why?
|
Asymptomatic Diseases | 3 | 2019 | 552 | 0.090 |
Why?
|
Tai Ji | 1 | 2014 | 284 | 0.090 |
Why?
|
Problem Solving | 1 | 2012 | 440 | 0.090 |
Why?
|
Pyridines | 1 | 2022 | 2818 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2018 | 15530 | 0.090 |
Why?
|
Latin America | 2 | 2020 | 381 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39004 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2017 | 2013 | 0.080 |
Why?
|
Colombia | 2 | 2019 | 259 | 0.080 |
Why?
|
Carbolines | 2 | 2019 | 265 | 0.080 |
Why?
|
Alleles | 1 | 2019 | 6931 | 0.080 |
Why?
|
Ethylene Glycols | 2 | 2019 | 156 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2017 | 2658 | 0.070 |
Why?
|
Neural Pathways | 1 | 2018 | 2971 | 0.070 |
Why?
|
Biomedical Research | 1 | 2021 | 3306 | 0.060 |
Why?
|
Nerve Net | 1 | 2017 | 2174 | 0.060 |
Why?
|
Life Style | 2 | 2023 | 3824 | 0.060 |
Why?
|
Learning | 1 | 2014 | 1705 | 0.060 |
Why?
|
Psoriasis | 1 | 2012 | 898 | 0.060 |
Why?
|
Trust | 1 | 2009 | 501 | 0.060 |
Why?
|
Neurogranin | 1 | 2022 | 15 | 0.060 |
Why?
|
Repression, Psychology | 1 | 2022 | 44 | 0.050 |
Why?
|
Dementia | 1 | 2017 | 2501 | 0.050 |
Why?
|
Risk | 1 | 2015 | 9679 | 0.050 |
Why?
|
Informed Consent | 1 | 2009 | 991 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4029 | 0.050 |
Why?
|
European Union | 1 | 2021 | 157 | 0.050 |
Why?
|
Attitude to Health | 1 | 2009 | 2051 | 0.040 |
Why?
|
Culture | 1 | 2023 | 632 | 0.040 |
Why?
|
Patient Compliance | 1 | 2009 | 2680 | 0.040 |
Why?
|
Thiones | 1 | 2017 | 46 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17400 | 0.040 |
Why?
|
Palmitates | 1 | 2017 | 74 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 53187 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2017 | 6030 | 0.040 |
Why?
|
Contrast Media | 2 | 2019 | 5295 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 9274 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 975 | 0.030 |
Why?
|
Computers, Handheld | 1 | 2017 | 208 | 0.030 |
Why?
|
Sex Factors | 2 | 2019 | 10392 | 0.030 |
Why?
|
Adult | 7 | 2021 | 213712 | 0.030 |
Why?
|
Tongue | 1 | 2017 | 406 | 0.030 |
Why?
|
Pilot Projects | 2 | 2017 | 8297 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 939 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 29717 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 780 | 0.030 |
Why?
|
Skin Diseases, Infectious | 1 | 2012 | 74 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2533 | 0.030 |
Why?
|
Gyrus Cinguli | 1 | 2018 | 1088 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14720 | 0.030 |
Why?
|
Forecasting | 1 | 2020 | 2948 | 0.020 |
Why?
|
Interleukin-23 | 1 | 2012 | 193 | 0.020 |
Why?
|
Apolipoproteins E | 1 | 2017 | 1438 | 0.020 |
Why?
|
Leadership | 1 | 2020 | 1357 | 0.020 |
Why?
|
Interleukin-12 | 1 | 2012 | 579 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2187 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2022 | 5095 | 0.020 |
Why?
|
Cohort Studies | 3 | 2018 | 40450 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3210 | 0.020 |
Why?
|
Drug and Narcotic Control | 1 | 2009 | 146 | 0.020 |
Why?
|
Carcinoma, Basal Cell | 1 | 2012 | 545 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5611 | 0.020 |
Why?
|
Brain Concussion | 1 | 2018 | 1318 | 0.020 |
Why?
|
Information Dissemination | 1 | 2015 | 1100 | 0.020 |
Why?
|
Prognosis | 2 | 2017 | 29010 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7770 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3328 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2009 | 736 | 0.010 |
Why?
|
Brain Mapping | 1 | 2018 | 6669 | 0.010 |
Why?
|
Drug Industry | 1 | 2009 | 744 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13403 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2022 | 62966 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 72145 | 0.010 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15108 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168561 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 8925 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15494 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29087 | 0.010 |
Why?
|
Caregivers | 1 | 2009 | 2074 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20086 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4029 | 0.010 |
Why?
|
Prevalence | 1 | 2012 | 15194 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 77098 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5662 | 0.010 |
Why?
|
United States | 1 | 2021 | 69693 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 56350 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85649 | 0.010 |
Why?
|
Concepts
(168)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_